Skip to main content

Advertisement

Table 1 Demographics and clinicopathological parameters in patients with PDAC

From: Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma

Variables PDAC (N = 85)
Age: Mean ± SD (years) 65 ± 10
Gender
 Male 55 (65%)
 Female 30 (35%)
Tumor size
  ≤ 2 cm 18 (21%)
  > 2 cm 67 (79%)
Tumor location
 Head 63 (74%)
 Tail 22 (26%)
LN metastasis 54 (64%)
LVI 40 (48%)
PNI 61 (72%)
No neoadjuvant 75 (88%)
Stage
 Stage I, II 24 (28%)
 Stage III, IV 61 (72%)
Tumor grade
 Low grade (1/2) 56 (66%)
 High grade (3) 29 (34%)
  1. Abbreviations: PDAC pancreatic ductal adenocarcinoma;
  2. SD standard deviation, LVI lymphovascular invasion;
  3. LN lymph node, PNI perineural invasion